BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26025060)

  • 1. Total glucosides of peony attenuates experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Huang Q; Ma X; Zhu DL; Chen L; Jiang Y; Zhou L; Cen L; Pi R; Chen X
    J Neuroimmunol; 2015 Jul; 284():67-73. PubMed ID: 26025060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise.
    Bernardes D; Oliveira-Lima OC; Silva TV; Faraco CC; Leite HR; Juliano MA; Santos DM; Bethea JR; Brambilla R; Orian JM; Arantes RM; Carvalho-Tavares J
    J Neuroimmunol; 2013 Nov; 264(1-2):24-34. PubMed ID: 24054000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Zhu D; Liu M; Yang Y; Ma L; Jiang Y; Zhou L; Huang Q; Pi R; Chen X
    J Neurosci Res; 2014 Sep; 92(9):1217-26. PubMed ID: 24798871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing the BDNF and NGF loss involved in the effects of cornel iridoid glycoside on attenuation of experimental autoimmune encephalomyelitis in mice.
    Qu Z; Zheng N; Zhang Y; Zhang L; Liu J; Wang Q; Yin L
    Neurol Res; 2016 Sep; 38(9):831-7. PubMed ID: 27373350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
    Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Chen X; Pi R; Liu M; Ma X; Jiang Y; Liu Y; Mao X; Hu X
    J Neuroimmunol; 2010 Sep; 226(1-2):104-9. PubMed ID: 20538348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
    Benson CA; Wong G; Tenorio G; Baker GB; Kerr BJ
    Behav Brain Res; 2013 Sep; 252():302-11. PubMed ID: 23777648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 expression patterns during the progression of experimental autoimmune encephalomyelitis.
    Sun Y; Chen H; Dai J; Zou H; Gao M; Wu H; Ming B; Lai L; Xiao Y; Xiong P; Xu Y; Gong F; Zheng F
    J Neuroimmunol; 2015 Mar; 280():29-35. PubMed ID: 25773152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
    Yao SQ; Li ZZ; Huang QY; Li F; Wang ZW; Augusto E; He JC; Wang XT; Chen JF; Zheng RY
    J Neurochem; 2012 Oct; 123(1):100-12. PubMed ID: 22639925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGS10 deficiency ameliorates the severity of disease in experimental autoimmune encephalomyelitis.
    Lee JK; Kannarkat GT; Chung J; Joon Lee H; Graham KL; Tansey MG
    J Neuroinflammation; 2016 Feb; 13():24. PubMed ID: 26831924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen induces multiple regulatory B cell subtypes and promotes M2 microglia and neuroprotection during experimental autoimmune encephalomyelitis.
    Benedek G; Zhang J; Bodhankar S; Nguyen H; Kent G; Jordan K; Manning D; Vandenbark AA; Offner H
    J Neuroimmunol; 2016 Apr; 293():45-53. PubMed ID: 27049561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis.
    Ge Z; Da Y; Xue Z; Zhang K; Zhuang H; Peng M; Li Y; Li W; Simard A; Hao J; Yao Z; Zhang R
    Exp Neurol; 2013 Mar; 241():56-66. PubMed ID: 23261766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-BFI ameliorates EAE-induced mouse spinal cord damage: effective therapeutic time window and possible mechanisms.
    Li F; Zhang ZX; Liu YF; Xu HQ; Hou ST; Zheng RY
    Brain Res; 2012 Nov; 1483():13-9. PubMed ID: 22985669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primaquine treatment suppresses experimental autoimmune encephalomyelitis severity.
    Zanucoli F; Thomé R; Bonfanti AP; de Carvalho AC; Issayama LK; da Costa TA; Di Gangi R; Ferreira IT; Bombeiro AL; de Oliveira AL; Verinaud L
    CNS Neurosci Ther; 2014 Dec; 20(12):1061-4. PubMed ID: 25417930
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic exercise confers neuroprotection in experimental autoimmune encephalomyelitis.
    Pryor WM; Freeman KG; Larson RD; Edwards GL; White LJ
    J Neurosci Res; 2015 May; 93(5):697-706. PubMed ID: 25510644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood-brain barrier-permeable catechol-O-methyltransferase inhibitor dinitrocatechol suppresses experimental autoimmune encephalomyelitis.
    Polak PE; Lin SX; Pelligrino D; Feinstein DL
    J Neuroimmunol; 2014 Nov; 276(1-2):135-41. PubMed ID: 25242632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
    J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.